St Jude Medical has launched Epiducer lead delivery system, for neurostimulation therapy for the management of chronic pain, in Australia.
The Epiducer system is the latest addition to the St Jude Medical product portfolio which includes neurostimulator for chronic pain – the Eon Mini spinal cord stimulator.
The Epiducer lead delivery system gives physicians the ability to place multiple neurostimulation leads through a single entry point, including proprietary S-Series steerable paddle leads, which are designed for minimally invasive placement.
The system is designed to lessen procedural complexities and improve efficiency in the placement of neurostimulation leads utilized in spinal cord stimulation (SCS) therapy for the management of chronic pain.
St Jude Medical Neuromodulation Division president Chris Chavez said providing physicians with clinically relevant new products like the Epiducer system enables them to have more control and less procedural risks when providing patients with this life-changing therapy.